A report related to extrahepatic biliary atresia (BA) (36), CD177+ neutrophils have been observed to exacerbate bile duct injury through NET release, treatment with NET inhibitors has demonstrated a reduction in the number of CD177+ neutrophils and ROS production, underscoring the potential therapeutic benefits of these inhibitors. This evidence concerns the gene CD177 and breast angiosarcoma.